Cargando…

Why do experts on ectodermal dysplasia (ED) meet again?

Detalles Bibliográficos
Autor principal:	Bergendal, Birgitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360384/ http://dx.doi.org/10.1186/1746-160X-8-S1-I1

Ejemplares similares

Pathogenesis of ectodermal dysplasia
por: Thesleff, Irma
Publicado: (2012)

Dermatologic aspects of ectodermal dysplasias
por: Itin, Peter H
Publicado: (2012)

Animal models of ectodermal dysplasia
por: Leeb, Tosso
Publicado: (2012)

Early recognition of hypohidrotic ectodermal dysplasia
por: Schneider, Holm
Publicado: (2012)

Hypohidrotic ectodermal dysplasia and physical exercise
por: Hammersen, Johanna E
Publicado: (2012)

Prosthodontic treatment of patients with ectodermal dysplasia
por: Weber, Heiner
Publicado: (2012)

Involvement of the ocular system in hypohidrotic ectodermal dysplasia
por: Kaercher, Thomas
Publicado: (2012)

Ectodermal dysplasia-related disorders of the respiratory tract
por: Fete, Timothy J
Publicado: (2012)

Heterozygote manifestations in X-chromosomal ectodermal dysplasia
por: Gal, Andreas
Publicado: (2012)

Long-term results of implant-based functional rehabilitation of patients with ectodermal dysplasia
por: Reinert, Siegmar
Publicado: (2012)

Ectodermal dysplasia (ED) syndrome
por: Chee, Siew-Yin, et al.
Publicado: (2014)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

Missing heritability and missing Fst of candidate genes: why does gene variation differ from trait variation in trees?
por: Kremer, Antoine
Publicado: (2011)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

Multidisciplinary treatment in children with ectodermal dysplasia
por: Norderyd, J
Publicado: (2012)

EDAR-induced hypohidrotic ectodermal dysplasia: a clinical study on signs and symptoms in individuals with a heterozygous c.1072C > T mutation
por: Falk Kieri, Catarina, et al.
Publicado: (2014)

X-linked anhidrotic ectodermal dysplasia (ED1) in men, mice, and cattle
por: Drögemüller, Cord, et al.
Publicado: (2003)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

What happens after hepatitis C eradication?
por: Pol, Stanislas
Publicado: (2012)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

How to keep a patient support group running?
por: Gomez, Karla Padilla, et al.
Publicado: (2012)

Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012)

The long way from bench to bedside
por: Gaide, Olivier
Publicado: (2012)

Novel genetic findings
por: Bohring, Axel
Publicado: (2012)

EDI200 therapeutic trial
por: Huttner, Kenneth
Publicado: (2012)

Update on HIV pandemic
por: Ekstrom, Anna Mia
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cisj7glu19chp1m1hglubo986v